EVALUATION OF THE EFFECTIVENESS OF ANTI-MULLERIAN HORMONE IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME

Sarah Muftah Khalifa* and Dr. Ibrahim Abu Shanab

ABSTRACT

Polycystic ovary syndrome is one of the most common endocrine disorders in women of childbearing age, and in view of the complications it causes that have a negative impact on the nature of the lives of affected women. Wadi Al-Shati area according to Rotterdam criteria and evaluated the efficiency of AMH in diagnosing this syndrome. The study included 50 women diagnosed with PCOS by ultrasound, their ages ranged between 25-45 years, divided into two groups according to the incidence of the syndrome. Objective: To evaluate whether anti-Müllerian hormone (AMH) can be used as a diagnostic marker for polycystic ovary syndrome (PCOS). Materials and Methods: In this study, 50 samples were collected from female donors who were recently diagnosed with polycystic ovary syndrome (PCOS) by ultrasound. Among them were samples of healthy women who did not suffer from the syndrome as a control sample who visited the infertility center in the city of Sabha. They were from different areas of the city of Sabha and its suburbs, as well as a number of women who visited Al-Sara Clinic, Al-Firdaws Clinic and Al-Amal Clinic in the Brak Al-Shati area. Results: The results of this study showed no significant differences in AMH concentration levels between women with PCOS and healthy women under study. Conclusion: The results of this study showed an increase in the number of women with the syndrome in the age group (26-30 years), and no significant differences in the concentration of AMH between the two groups, as the P-Value was higher than 0.05, while it showed the presence of significant differences in the concentration of LH and age, and the P-Value was less than 0.05.

Keywords: Menstrual disorders, AMH, PCOs.